To: Office of Management and Budget (OMB)
Through: Keith Tucker, Report Clearance Officer, HHS
Seleda Perryman, Program Officer, Project Clearance Branch, NIH
From: Vivian Horovitch-Kelley, NCI OMB Project Clearance Liaison,
National Cancer Institute (NCI)/NIH
Subject: Bundled Generic Sub-Studies for:
OMB Numbers: 0925-0046-20, 21, and 22
This is a bundled generic sub-study submission of three projects. These studies represent collaboration between Office of Communications and Education (OCE) and other Divisions at NCI. All three sub-studies involve clinical trials; two of them look at testing new informed consents (#20 and #22) and the third is looking at clinical trial accrual.
The key to understanding the attachments and files in ICRAS/ROCIS is as listed below.
Sub-study #20: Formative Evaluation of Concise Informed Consent Document (ICD)
Short Title: Concise ICD
Files and attachments are labeled “#20” and include:
Justification Memo and Attachments 20A (Email Invitation) and 20D (Patient-Friendly Educational Materials)
Attachment 20B (Screener)
Attachment 20C (Survey Screenshots)
Sub-study #21: Revision of Rapid Feedback Tool to Identify Accrual Problems with Active NCI Clinical Trials
Short Title: Accrual CT
Attachments are labeled “#21” and include:
Justification Memo and Attachment 21E (Email Invitation)
Attachments 21A (Oncology Survey), 21B (Staff Survey), 21C (Concept
Feedback Survey), and 21D (Prospective Template)
Sub-study #22: Formative Audience Research for Spanish Template Informed
Consent Form
Short Title: Consent
Files and attachments are labeled “#22” and include:
Justification Memo and Attachments 22F (Consent Form)
Attachment 22A (Screener)
Attachments 22B and 22C (Interview Guides in English and Spanish)
Attachments 22D and 22E (Sample Consent Templates in Spanish and English)
Estimates of Hour Burden for Sub-Studies #20, #21 and #22 |
|||||
Type of Respondents |
Instruments |
Number of Respondents |
Frequency of Response |
Average Response Time (minutes/hour) |
Hour Burden |
Patients with Colorectal Cancer (Sub-study #20) |
Screener (Attachment 20B) |
190 |
1 |
10/60 |
32 |
Survey (Attachment 20B) |
150 |
1 |
60/60 |
150 |
|
Oncologists and Research Staff for NCI-Sponsored Trials (Sub-study #21) |
Oncology Feedback Survey (Attachment 21A) |
[456] |
1 |
5/60 |
[38] |
Staff Feedback Survey (Attachment 21B) |
[456] |
1 |
5/60 |
[38] |
|
Concept Feedback Survey (Attachment 21C) |
[456] |
1 |
5/60 |
[38] |
|
Prospective Template (Attachment 21D) |
[456] |
1 |
5/60 |
[38] |
|
General Public (Sub-study #22) |
Screener (Attachment 22A) |
80 |
1 |
15/60 |
20 |
Latino adults eligible for prevention or treatment clinical trial (Sub-study #22) |
In-depth Interview Guide (Attachment 22B and 22C) |
30 |
1 |
1 |
30 |
Total |
|
|
|
|
232 |
Notes to OMB:
The respondents and hour burden for sub-study #21 are in square brackets [ ] because these burden hours were already requested and approved by OMB #0925-0046-15 on June 15, 2011. This sub-study has not begun information collection and is requesting to add two additional surveys. The total number of respondents and burden will not change from what was originally approved.
The “Category of Respondents” is individuals for all three sub-studies.
Total number of responses = 450
File Type | application/msword |
File Title | Date: |
Author | anisz |
Last Modified By | Vivian Horovitch-Kelley |
File Modified | 2012-03-29 |
File Created | 2012-03-29 |